International Stem Cell (ISCO) Gross Margin (2016 - 2025)
International Stem Cell (ISCO) has disclosed Gross Margin for 16 consecutive years, with 87.18% as the latest value for Q1 2025.
- On a quarterly basis, Gross Margin rose 287.0% to 87.18% in Q1 2025 year-over-year; TTM through Mar 2025 was 87.29%, a 344.0% increase, with the full-year FY2024 number at 86.62%, up 261.0% from a year prior.
- Gross Margin was 87.18% for Q1 2025 at International Stem Cell, down from 88.23% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 156.75% in Q4 2023 to a low of 19.55% in Q4 2022.
- A 5-year average of 76.7% and a median of 84.07% in 2022 define the central range for Gross Margin.
- Peak YoY movement for Gross Margin: surged 13720bps in 2023, then plummeted -6852bps in 2024.
- International Stem Cell's Gross Margin stood at 60.12% in 2021, then tumbled by -67bps to 19.55% in 2022, then surged by 702bps to 156.75% in 2023, then tumbled by -44bps to 88.23% in 2024, then dropped by -1bps to 87.18% in 2025.
- Per Business Quant, the three most recent readings for ISCO's Gross Margin are 87.18% (Q1 2025), 88.23% (Q4 2024), and 86.6% (Q3 2024).